|
1
|
Wang D, Wang L, Zhou J, Pan J, Qian W, Fu
J, Zhang G, Zhu Y, Liu C, Wang C, Jin Z, He Z, Wu J and Shi B:
Reduced expression of PTPRD correlates with poor prognosis in
gastric adenocarcinoma. PLoS One. 11:e1137542014. View Article : Google Scholar
|
|
2
|
Yang X, Takano Y and Zheng HC: The
pathobiological features of gastrointestinal cancers (Review).
Oncol Lett. 3:961–969. 2012.PubMed/NCBI
|
|
3
|
von Lindern M, Fornerod M, van Baal S,
Jaegle M, de Wit T, Buijs A and Grosveld G: The translocation
(6;9), associated with a specific subtype of acute myeloid
leukemia, results in the fusion of two genes, dek and can and the
expression of a chimeric, leukemia-specific dek-can mRNA. Mol Cell
Biol. 12:1687–1697. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wise-Draper TM, Allen HV, Jones EE, Habash
KB, Matsuo H and Wells SI: Apoptosis inhibition by the human DEK
oncoprotein involves interference with p53 functions. Mol Cell
Biol. 26:7506–7519. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wise-Draper TM, Mintz-Cole RA, Morris TA,
Simpson DS, Wikenheiser-Brokamp KA, Currier MA, Cripe TP, Grosveld
GC and Wells SI: Overexpression of the cellular DEK protein
promotes epithelial transformation in vitro and in vivo. Cancer
Res. 69:1792–1799. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu Q, Li Z, Lin H, Han L, Liu S and Lin Z:
DEK overexpression in uterine cervical cancers. Pathol Int.
58:378–382. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Orlic M, Spencer CE, Wang L and Gallie BL:
Expression analysis of 6p22 genomic gain in retinoblastoma. Genes
Chromosomes Cancer. 45:72–82. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Carro MS, Spiga FM, Quarto M, Di Ninni V,
Volorio S, Alcalay M and Müller H: DEK expression is controlled by
E2F and deregulated in diverse tumor types. Cell Cycle.
5:1202–1207. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Datta A, Adelson ME, Mogilevkin Y,
Mordechai E, Sidi AA and Trama JP: Oncoprotein DEK as a tissue and
urinary biomarker for bladder cancer. BMC Cancer. 11:2342011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mohan S, Abdelwahab SI, Kamalidehghan B,
Syam S, May KS, Harmal NS, Shafifiyaz N, Hadi AH, Hashim NM,
Rahmani M, et al: Involvement of NF-κB and Bcl2/Bax signaling
pathways in the apoptosis of MCF7 cells induced by a xanthone
compound pyranocycloartobiloxanthone A. Phytomedicine.
19:1007–1015. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Khaw AK, Yong JW, Kalthur G and Hande MP:
Genistein induces growth arrest and suppresses telomerase activity
in brain tumor cells. Genes Chromosomes Cancer. 51:961–974. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lupescu A, Jilani K, Zbidah M and Lang F:
Induction of apoptotic erythrocyte death by rotenone. Toxicology.
300:132–137. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Han S, Xuan Y, Liu S, Zhang M, Jin D, Jin
R and Lin Z: Clinicopathological significance of DEK overexpression
in serous ovarian tumors. Pathol Int. 59:443–447. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin L, Piao J, Gao W, Piao Y, Jin G, Ma Y,
Li J and Lin Z: DEK overexpression as an independent biomarker for
poor prognosis in colorectal cancer. BMC Cancer. 13:366–345. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Edge S, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual (7th). New York,
NY: Springer-Verlag New York. 2010.
|
|
16
|
Marchet A, Mocellin S, Ambrosi A, Morgagni
P, Vittimberga G, Roviello F, Marrelli D, de Manzoni G, Minicozzi
A, Coniglio A, et al: Validation of the new AJCC TNM staging system
for gastric cancer in a large cohort of patients (n=2,155): Focus
on the T category. Eur J Surg Oncol. 37:779–785. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Köbel M, Weichert W, Crüwell K, Schmitt
WD, Lautenschläger C and Hauptmann S: Epithelial hyaluronic acid
and CD44v6 are mutually involved in invasion of colorectal
adenocarcinomas and linked to patient prognosis. Virchows Arch.
445:456–464. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lazăr D, Tăban S, Raica M, Sporea I,
Cornianu M, Goldiş A and Vernic C: Immunohistochemical evaluation
of the tumor neoangiogenesis as a prognostic factor for gastric
cancers. Rom J Morphol Embryol. 49:137–148. 2008.PubMed/NCBI
|
|
19
|
Kappes F, Burger K, Baack M, Fackelmayer
FO and Gruss C: Subcellular localization of the human
proto-oncogene protein DEK. J Biol Chem. 276:26317–26323. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Killeen MR: Integrating a neurobiological
systems approach into child neglect and abuse theory and practice.
J Child Fam Nurs. 2:406–407. 1999.PubMed/NCBI
|
|
21
|
Kavanaugh GM, Wise-Draper TM, Morreale RJ,
Morrison MA, Gole B, Schwemberger S, Tichy ED, Lu L, Babcock GF,
Wells JM, et al: The human DEK oncogene regulates DNA damage
response signaling and repair. Nucleic Acids Res. 39:7465–7476.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vinnedge Privette LM, McClaine R, Wagh PK,
Wikenheiser-Brokamp KA, Waltz SE and Wells SI: The human DEK
oncogene stimulates β-catenin signaling, invasion and mammosphere
formation in breast cancer. Oncogene. 30:2741–2752. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Abba MC, Sun H, Hawkins KA, Drake JA, Hu
Y, Nunez MI, Gaddis S, Shi T, Horvath S, Sahin A and Aldaz CM:
Breast cancer molecular signatures as determined by SAGE:
Correlation with lymph node status. Mol Cancer Res. 5:881–890.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
ONCOMINE: A cancer microarray database and integrated data-mining
platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shibata T, Kokubu A, Miyamoto M, Hosoda F,
Gotoh M, Tsuta K, Asamura H, Matsuno Y, Kondo T, Imoto I, et al:
DEK oncoprotein regulates transcriptional modifiers and sustains
tumor initiation activity in high-grade neuroendocrine carcinoma of
the lung. Oncogene. 29:4671–4681. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin L, Piao J, Ma Y, Jin T, Quan C, Kong
J, Li Y and Lin Z: Mechanisms underlying cancer growth and
apoptosis by DEK overexpression in colorectal cancer. PLoS One.
9:e1112602014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kappes F, Fahrer J, Khodadoust MS, Tabbert
A, Strasser C, Mor-Vaknin N, Moreno-Villanueva M, Bürkle A,
Markovitz DM and Ferrando-May E: DEK is a poly(ADP-ribose) acceptor
in apoptosis and mediates resistance to genotoxic stress. Mol Cell
Biol. 28:3245–3257. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Khodadoust MS, Verhaegen M, Kappes F, et
al: Melanoma proliferation and chemoresistance controlled by the
DEK oncogene. Cancer Res. 69:6405–6413. 2009. View Article : Google Scholar : PubMed/NCBI
|
